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Pmpact of Beta-Myosin Heavy Chain
xpression on Cardiac Function During Stress
aike Krenz, MD, Jeffrey Robbins, PHD
incinnati, Ohio
OBJECTIVES In failing mouse and human hearts, a shift in myosin heavy chain (MHC) isoform content
from alpha to beta can occur. However, the impact of this phenomenon on disease
progression is not well understood. Therefore, using transgenic (TG) mice, we tested how a
pre-existing shift from alpha- to beta-MHC affects cardiac function under chronic mechan-
ical or pharmacologic cardiovascular stress.
BACKGROUND Expression of beta-MHC is considered to be energetically favorable, but this might be offset
by depressed cardiac function.
METHODS Transgenic mice with near-complete replacement of the normally predominant alpha- with
beta-MHC were subjected to cardiac stress.
RESULTS At baseline, TG mice show moderately reduced cardiac contractile function but are otherwise
healthy with normal ventricular morphology. After four weeks of swimming, both TG and
non-TG animals showed a 20% increase in left ventricular (LV)/body weight ratios. The TG
hearts displayed mildly greater end-diastolic and end-systolic LV diameters than nontrans-
genic hearts after training, but no signs of LV failure were observed. However, chronic
stimulation with isoproterenol resulted in augmented LV hypertrophy with signs of LV
decompensation in TG mice. Furthermore, in a post-infarction failure model, TG hearts
displayed accelerated LV dilation and a faster decline of shortening fraction.
CONCLUSIONS Expression of beta-MHC appears to be disadvantageous to the mice under severe cardio-
vascular stress, implying that the alpha3beta-MHC isoform shift observed in cardiac disease
may be a maladaptive response. (J Am Coll Cardiol 2004;44:2390–7) © 2004 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.044American College of Cardiology Foundation
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txpression of alpha- and beta-myosin heavy chain (MHC),
he two functionally distinct cardiac MHC isoforms is
pecies-dependent and tightly controlled by developmental
nd hormonal factors (1,2). Relative expression levels of
hese isoforms can be altered in disease states such as cardiac
ailure or hypertrophy (3). For example, in failing adult
ouse hearts, a shift from the normally predominant
lpha-MHC toward beta-MHC is often observed (4).
imilarly, up-regulation of beta-MHC transcription can
erve as an early and sensitive marker of cardiac hypertrophy
5). Importantly, recent evidence shows that alpha-MHC
xpression is down-regulated in human hearts as well (6–8).
lthough beta-MHC is the predominant isoform in normal
dult human hearts, it has been suggested that even small
hifts in relative isoform expression can significantly alter
ardiomyocyte power output (9). Beta-MHC is character-
zed by lower adenosine triphosphatase activity and lower
lament sliding velocity, but can generate cross-bridge force
ith a higher economy of energy consumption than alpha-
HC (10–12). This suggests that a shift from alpha- to
eta-MHC might be an adaptative response in order to
reserve energy. On the other hand, depressed contractile
unction can promote disease progression (13,14). There-
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ccepted September 14, 2004.ore, it is conceivable that the decrease in contractile
unction due to increased beta-MHC might outweigh the
enefits of improved economy and ultimately dictate clinical
utcome. It has recently been shown that improvement of
eft ventricular (LV) function is associated with a coordinate
ncrease in alpha- and a decrease in beta-MHC messenger
ibonucleic acid (mRNA) expression in patients with idio-
athic dilative cardiomyopathy (15). These findings support
he notion that increased beta-MHC expression may have a
etrimental effect on failing hearts. However, apart from
ircumstantial evidence, there are no direct data available to
esolve this controversy.
The present study was designed to investigate the impact
f the two cardiac MHC isoforms on cardiac function and
heir role during cardiovascular stress. Our aim was to
ddress the critical question of whether increased beta-
HC expression has a beneficial or detrimental effect on
he failing heart. Although not directly comparable to
HC isoform shifts in failing human hearts because of the
soform differences between the two, we decided to use a
ouse model with near-complete replacement of alpha-
HC with beta-MHC, because this would allow us to test
proof-of-principle in a well-defined animal model with
ltered cardiac isoform content. Previously, we generated
ransgenic (TG) mice expressing predominantly beta-MHC
nstead of alpha-MHC in the heart to study how the
educed mechanical function of beta-MHC observed in
itro was reflected in vivo (16). As expected, cardiac con-
ractile function was significantly reduced in vivo, but
nimals were healthy, had a normal life span, and showed no
c
T
s
I
h
c
l
M
T
d
a
m
s
r
p
d
i
n
a
c
T
n
F
g
a
A
i
(
t
P
m
l
b
b
a
s
t
a
i
f
n
C
t
C
u
i
M
p
d
I
a
d
m
m
a
3
m
a
(
(
a
s
i
t
b
2
a
A
w
e
c
a
S
w
c
c
f
u
R
P
(
g
T
N
T
N
T
*
2391JACC Vol. 44, No. 12, 2004 Krenz and Robbins
December 21, 2004:2390–7 MHC and Cardiac Stressardiac pathology at the light or electron microscope levels.
hese data indicated that the alpha3beta-MHC isoform
hift is well tolerated and by itself does not induce disease.
n the present study, these TG mice were used to investigate
ow a pre-existing shift from alpha- to beta-MHC affects
ardiac function under chronic mechanical or pharmaco-
ogic cardiovascular stress.
ETHODS
ransgenic animals. All animal procedures were in accor-
ance with National Institutes of Health guidelines and
pproved by the Institutional Animal Care and Use Com-
ittee. We previously generated TG mice with cardiac-
pecific expression of beta-MHC (16). The cardiomyocyte
igidly controls overall stoichiometry of the sarcomeric
rotein pool, such that increased TG at the mRNA level
oes not lead to increases in total protein (17); that is, there
s no “overexpression.” The steady-state levels of endoge-
ous protein are down-regulated and replaced proportion-
lly by the TG protein. Therefore, we achieved near-
omplete replacement of endogenous alpha-MHC with the
G protein. Normally, adult mouse cardiomyocytes contain
early 100% alpha-MHC. In this study, two different
VB/N mouse lines were used: line 102 bred to homozy-
osity with 73% replacement of alpha- with beta-MHC,
nd line 137 heterozygotes with 84% protein replacement.
part from mild left atrial enlargement in line 137 (but not
n line 102), the morphology of the TG hearts was normal
16), and the life spans in both lines did not differ from
hose of NTG animals.
ost-infarction failure model. Three-month-old male
ice under isoflurane anesthesia were intubated and venti-
ated. After lateral thoracotomy, the anterior descending
ranch of the left coronary artery was ligated 1 to 2 mm
elow the left auriculum. Cyanosis and akinesia of the
ffected area confirmed complete ligation of the vessel. In
ham operations, the suture was passed under the artery at
he same location. The chest was closed, and the animal
able 1. Post-infarction Body Weights, Organ Weights, and Infa
Body Weight
(g)
LV Weight
(mg)
LV/Bod
Ratio
TG sham 32.8  0.8 100  2 3.0 
G sham 32.2  0.8 101  2 3.1 
TG infarct 32.4 0.8 111  3† 3.4 
G infarct 28.8  1.2 118  4† 4.1 
Abbreviations and Acronyms
dP/dtmax  first derivative of left ventricular pressure
LV  left ventricle/ventricular
MHC  myosin heavy chain
NTG  nontransgenic
TG  transgenicp  0.05 NTG infarct versus TG infarct. †p  0.05 infarct versus sham. n  8 to 10 in sh
LV  left ventricular; NTG  nontransgenic; TG  transgenic.llowed to recover. Serial echocardiographic studies under
soflurane anesthesia were performed to monitor heart
unction. After sacrifice, endocardial areas of infarcted and
on-infarcted myocardium were planimetered (18).
hronic isoproterenol challenge. Under isoflurane anes-
hesia, subcutaneous osmotic pumps (Durect Corp.,
upertino, California) were implanted between the scap-
lae in 2- to 3-month-old female mice and 60 mg/kg/day
soproterenol in 0.02% ascorbic acid (Sigma, St. Louis,
issouri), or vehicle only was delivered. Systemic blood
ressure was measured in conscious mice using a tail-cuff
evice (Visitech Systems, Apex, North Carolina).
nvoluntary exercise. Male 2-month-old mice were
dapted by beginning with 10-min swimming sessions twice
aily, 7 days a week. Session length was increased by 10
in/day until reaching 90 min, then continued at twice 90
in through to day 28. Mice swam in tanks with a surface
rea of 225 cm2 per mouse and a water temperature of 30 to
2°C. Mice were continuously monitored to ensure that
ice could not rest by floating or climbing onto weaker
nimals. Exercise capacity was evaluated using treadmills
Omnipacer LC4, Omnitech Electronics, Columbus, Ohio)
19). On days 24 to 26 of the swim training, mice were
dapted to the treadmills. On days 27 to 29, treadmills were
et at a 7° incline, and speed was increased in 10-min
ntervals from 15 to 20, 25, and 30 m/min. Beam breaks of
he infrared detection system installed at the end of the belt
efore the shock grid were counted, and data of days 27 to
9 were averaged. Echocardiography was performed before
nd after swim training.
cute dobutamine challenge. Cardiac hemodynamics
ere measured in intact, closed-chest anesthetized mice of
ither gender (20). Dobutamine was administered in in-
reasing concentrations (1 to 32 ng/min/g body weight),
nd LV pressures were recorded.
tatistics. Data are presented as the mean value SEM and
ere analyzed using InStat Version 2.03 (default settings). For
omparisons of data from two groups, t tests were used. For
omparisons of multiple groups, one-way analysis of variance
ollowed by the Tukey-Kramer multiple comparisons test was
sed. For all tests, p  0.05 was considered significant.
ESULTS
ost-infarction failure model. Thirty-one beta-TG mice
13 from line 102 and 18 from line 137) and 33 nontrans-
enic (NTG) littermates underwent coronary ligation. The
izes
eight
/g)
Lung Weight
(mg)
Liver Weight
(g)
Infarct Size
(%)
174  10 1.5 0.1
174  6 1.6  0.1
175  6 1.7  0.1 30.3  2.6
† 285  33*† 1.5 0.1 29.6  1.9rct S
y W
(mg
0.1
0.1
0.1
0.3*am groups; n  11 in infarct groups. Data are presented as the mean value  SEM.
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MHC and Cardiac Stress December 21, 2004:2390–7ata gathered from both line 102 and line 137 were similar
nd subsequently were grouped. Postoperatively, there were
o differences in survival between TG and NTG animals.
ithin the first 10 days after surgery, 54% of the TG mice
nd 60% of the NTG mice died due to either LV failure or
V rupture, whereas 90% of the 20 sham-operated animals
urvived. There were no further deaths during the protocol.
In the surviving animals, infarct size was no different
etween groups (30.3% of total LV endocardial area in NTG,
9.6% in TGs). Left ventricular weight was increased in both
roups but did not differ between NTG and TG animals after
nfarct (Table 1). Because TG mice lost 10% of their body
eight, this resulted in an increased LV/body weight ratio in
G mice. There was no difference in tibial length (NTG
ham: 17.7  0.1 mm: TG sham: 17.7  0.1 mm: NTG
igure 1. Echocardiographic assessment of left ventricular (LV) function
ransgenic (TG). *p  0.05 TG versus NTG. †p  0.05 infarct group vers
roup; n  10 in NTG sham group; n  8 in TG sham group).nfarct: 17.8  0.1 mm: TG infarct: 17.8  0.1 mm). dmportantly, lung weights were significantly higher in TG
nimals with infarcts, indicating substantial LV congestion
Table 1). In contrast, liver weights did not differ, indicating
hat congestion was restricted to the left side of the heart.
Left ventricular chamber size and function was studied in
wo-week intervals after surgery using echocardiography
Fig. 1). There were no significant differences between the
ham groups at any time. The NTG hearts displayed only a
ery mild loss in shortening fraction postoperatively,
hereas shortening fraction significantly and progressively
eclined in TG animals (Fig. 1A). Left ventricular chamber
ize significantly increased over time, but at a faster rate in
G mice (Figs. 1C and 1E). The septum and free wall
hickness did not change (data not shown). That we
bserved in NTG mice a much more subtle LV functional
r coronary ligation. Solid bars  nontransgenic (NTG); open bars 
pective sham group (n  11 in NTG infarct group; n  10 in TG infarctafte
us resecline, as reported by other groups using different mouse
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December 21, 2004:2390–7 MHC and Cardiac Stresstrains (3,18,21), is most likely due to the decreased suscep-
ibility toward heart failure exhibited by the FVB/N strain
22). We noted that NTG hearts showed only a minor
ncrease of beta-MHC protein (5%) at the end of the
wo-month follow-up period after infarction. In the TG
earts, the relative amount of beta-MHC was also de-
reased at this time point. The decrease was somewhat
ependent on the individual infarct size and, in some
nstances, dropped from 80% to 40% to 60% of total MHC.
ven in the face of this decrease, the beta-MHC isoform
hift resulted in faster functional deterioration as compared
ith the NTG hearts.
hronic isoproterenol infusion. As an alternative way of
tressing the cardiovascular system, TG and NTG animals
igure 2. (A) Systolic blood pressure after osmotic pump implantation (n
ump implantation. Solid bars  nontransgenic (NTG); open bars  tra
roup. ‡p  0.05 24 h versus 2 weeks (n  8 to 12). (C) Hematoxylin-eos
lveolar capillaries filled with erythrocytes in the TG lung (arrows).rom line 137 underwent two weeks of continuous infusion tf the beta-agonist isoproterenol. Blood pressure measure-
ents demonstrated that systemic blood pressure was lower
n TG compared with NTG animals after the first 24 h of
soproterenol infusion (Fig. 2A). At the end of the two-
eek infusion period, blood pressure recovered but did not
ise above baseline level. In contrast, the NTG animals
esponded with an increase in blood pressure within 24 h.
ver the two-week infusion period, blood pressure contin-
ed to rise in the NTG animals (Fig. 2A). The NTG
nimals showed a 22% increase in LV/body weight ratio,
hereas this ratio increased by 40% in TG mice (Table 2,
ig. 2B). Importantly, despite the more pronounced cardiac
ypertrophy exhibited by the TG mice, LV mass was not
ufficient to meet the hemodynamic demands under isopro-
o 11). (B) Ratio of left ventricular weight to body weight two weeks after
ic (TG). *p  0.05 TG versus NTG. †p  0.05 versus respective vehicle
ined 5-m sections of lung tissue. Note perivascular edema and engorged 9 t
nsgen
in–staerenol, resulting in increased wet lung weight (Table 2). In
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MHC and Cardiac Stress December 21, 2004:2390–7istologic sections, the lungs of the isoproterenol-treated
G mice showed areas with acute pulmonary congestion
nd edema (Fig. 2C). There was no change in the alpha-/
eta-MHC protein ratio induced by isoproterenol.
nvoluntary exercise. Both NTG and TG mice from line
37 tolerated the exercise regimen very well. During the
wimming sessions, no obvious differences in performance
ould be observed between TG and NTG animals. For
uantitative assessment of exercise capacity, treadmills were
sed. The number of beam breaks at various treadmill
peeds was no different between TG and NTG animals
Fig. 3A). Consistent with these data, no signs of LV
ongestion were detectable (wet lung weights in NTG
on-exercised 155  3 mg, TG non-exercised 145  6 mg,
able 2. Body and Organ Weights After Chronic Isoproterenol C
Body Weight
(g)
LV Weight
(mg)
RV W
(
TG vehicle 25.1 0.3 81  2 22
G vehicle 25.8 0.8 85  2 22
TG isoproterenol 26.8 0.4 106  4† 26
G isoproterenol 25.6 0.5 118  2*† 30
p  0.05 TG versus NTG. †p  0.05 vehicle versus isoproterenol. n  8 to 12 an
RV  right ventricular; other abbreviations as in Table 1.
igure 3. (A) Exercise capacity on the treadmill of transgenic (TG) (open
quares) and nontransgenic (NTG) (solid circles) mice at the end of the
our-week swim training. (B) Ratio of left ventricular (LV) weight to body
eight after four weeks in exercised and non-exercised groups. Solid barsb
NTG; open bars  TG. *p  0.05 versus respective non-exercised
roup (n  4 to 6 in each group).TG exercised 150  5 mg, TG exercised 142  4 mg).
ver the four-week training period, mice lost 15% to 17%
f their body weight (NTG non-exercised 31.3 1.3 g, TG
on-exercised 31 1.4 g, NTG exercised 26.8 0.6 g, TG
xercised 25.8  0.6 g*, *p  0.05 vs. respective non-
xercised group). The LV weights were no different between
roups (NTG non-exercised: 85  3 mg: TG non-
xercised: 86  1 mg: NTG exercised: 90  5 mg: TG
xercised: 88  2 mg). Consequently, the ratio of LV to
ody weight increased by 22% in NTG and TG animals
Fig. 3B).
Left ventricular function before and after training was
ompared using echocardiography (Fig. 4). Minor but not
ignificant differences in shortening fraction were found:
TG but not TG hearts improved slightly due to exercise
raining. Exercise training moderately increased end-systolic
hickness of the LV free wall in NTG but not in TG mice.
he diameters of TG LVs were slightly larger after training,
ut these differences did not reach statistical significance.
he relative amounts of alpha-/beta-MHC protein did not
hange in exercised NTG and TG animals.
cute dobutamine challenge. As previously reported (16),
ontractile function in TG hearts (line 102) was moderately
epressed at baseline. Dobutamine infusion increased LV
ontractile performance in both TG and NTG mice (Fig. 5).
owever, the positive inotropic response was less pro-
ounced in TG compared with NTG animals: dP/dtmax
ncreased in NTGs by 50% at the highest dobutamine
ose, but only by 30% over baseline in TGs (Fig. 5B).
he LV peak pressure increased at a similar rate in both
roups (Fig. 5A).
ISCUSSION
o gain insight into the impact that MHC isoform shifts
ight have on cardiac disease, we subjected TG mice stably
xpressing beta-MHC in the heart to chronic cardiovascular
tress. The data demonstrate that beta-TG hearts were at a
isadvantage under chronic isoproterenol challenge or in a
ost-infarction failure model. Therefore, the alpha3beta-
HC isoform shift associated with cardiac disease appears to
e detrimental rather than beneficial under these conditions.
It has been suggested that expression of beta-MHC
ould save intracellular energy due to the higher economy
f energy consumption (10,11). Considering that 75% of all
TP consumed in the cardiomyocyte is used for cross-
enge
ht Atrial Weight
(mg)
LV/Body Weight
Ratio (mg/g)
Lung Weight
(mg)
8  1 3.2  0.1 153  2
14  1* 3.3  0.1 148  5
13  1† 3.9  0.2† 168  5
23  2*† 4.6  0.1*† 207  14†
per group. Data are presented as the mean value  SEM.hall
eig
mg)
 1
 1
 2†
 2*†ridge cycling (23), even small changes in economy could
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December 21, 2004:2390–7 MHC and Cardiac Stressherefore lead to substantial alterations in overall energetic
omeostasis. Consequently, hearts predominantly express-
ng beta-MHC should be better equipped to handle the
ncreased energy demand under cardiovascular stress. How-
ver, the present data demonstrate that this postulated
dvantage has no significant bearing on the heart’s ability to
olerate chronic stress. This is consistent with a recent study
y Crilley et al. (24) on the cardiac bioenergetic deficit in
atients with familial hypertrophic cardiomyopathy. They
howed that energy metabolism was impaired in individuals
arrying three different mutations in the beta-MHC, car-
iac troponin T, or myosin-binding protein C genes.
mportantly, even in gene mutation carriers without hyper-
rophy, a bioenergetic deficit could be observed. Therefore,
lthough there is strong evidence for a link between cardiac
igure 4. Left ventricular (LV) function and chamber dimensions befo
ontransgenic (NTG); open bars  transgenic (TG). *p  0.05 before vnergetics and development of a disease phenotype in cumans and animals (25,26), energy availability alone can-
ot account for disease penetrance. Although beta-MHC
ay save intracellular energy, it appears that this is not the
etermining factor for the clinical outcome in the mice.
If not energy homeostasis, which factor then is respon-
ible for the accelerated disease progression observed in
eta-MHC–expressing mouse hearts? There is currently
uch controversy over the hypothesis that abnormalities in
ontractility initiate the heart failure syndrome and drive its
rogression (27). Although most studies agree that the
ontractility of failing human hearts is depressed, we lack
irect evidence as to whether this is a primary or secondary
vent. Clearly, contractile function is already depressed in
eta-TG mice under normal husbandry conditions, but the
HC isoform shift is well tolerated and does not induce
d after swim training, as assessed by echocardiography. Solid bars 
after swim training (n  5 or 6 in each group).re anardiac disease (16). However, in our post-infarction failure
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MHC and Cardiac Stress December 21, 2004:2390–7odel, contractile function of TG hearts deteriorates at a
aster rate and to a greater extent than in NTG controls,
mplying that depressed contractility may be a primary
vent. This interpretation is supported by numerous other
nimal studies showing that depressed contractility signifi-
antly contributes to the initiation and progression of heart
ailure (13,14).
Interestingly, beta-TG hearts respond to chronic cate-
holamine challenge not with a dilative phenotype as in the
ost-infarction failure model but with increased cardiac
ypertrophy. However, these differences were not reflected
t the molecular level, and the changes that did occur in
evels of the usual indicators, such as atrial natriuretic factor
r phospholamban, did not differ significantly between the
wo groups (data not shown). However, the adaptative
esponse clearly was insufficient to meet hemodynamic
emands under isoproterenol stimulation in beta-TG mice.
he interpretation of these experiments is limited by the
act that we cannot exclude that the peripheral vascular
ensitivity to isoproterenol is different in TG animals.
owever, if there were substantial differences in the re-
ponse of the peripheral vasculature to catecholamines,
igure 5. Hemodynamic parameters under acute dobutamine challenge in
ncreasing doses in the intact, closed-chest animal. (A) Left ventricular
ystolic peak pressure (LVP). (B) Maxima of the first derivative of left
entricular pressure (dP/dtmax). Solid squares  nontransgenic (NTG);
pen squares  transgenic (TG). *p  0.05 TG versus NTG (n  4 or 5
er group).hese should have become apparent in our endurance pxercise experiments. We could not detect any differences in
xercise capacity in mice running on treadmills.
The chronic isoproterenol challenge and the post-
nfarction studies indicate that the presence of a high level
f beta-MHC is detrimental under chronic cardiovascular
tress, presumably due to the decreased contractile perfor-
ance of the cardiomyocytes. However, a direct mechanis-
ic link between contractility and the development of heart
ailure is still lacking. It has been postulated that cellular
tress sensors located at or linked to the cytoskeleton are
mportant for the modulation of the cellular response to
echanical stress (28,29). It may be that such stress sensors
lso play an important role in modulating disease progres-
ion. Because these sensors are linked to the cytoskeleton,
heir signaling output would depend not only on external
orces but also on the ability of the cell to contract under
hese conditions. It is therefore conceivable that the readout
f mechanical stress sensors is altered in beta-TG mice,
hich may result in more pronounced remodeling, as
bserved both under isoproterenol challenge and in the
ost-infarction failure model. However, as the nature and
ownstream pathways of the postulated stress sensors re-
ain to be identified, the hypothesis is difficult to test at this
oint.
Furthermore, it is not known whether intracellular stress
ensors can distinguish between “physiologic” and “patho-
ogic” stresses, provided that these indeed are two distinct
ntities. Under mild, physiologic stress, both TG and NTG
earts showed a similar hypertrophic response without signs
f heart failure. It appears that the shift from alpha- to
eta-MHC can be compensated for under physiologic
ndurance exercise, but counterbalancing mechanisms be-
ome overwhelmed under more intense cardiovascular
train. Whether this is universally true for all forms of
athologic cardiovascular stress remains to be determined.
We were interested in quantifying the amount of cardiac
eserve available in beta-TG mice and measured the hemo-
ynamic response to increasing doses of dobutamine in a
losed-chest preparation. As expected, the TG hearts dis-
layed a considerable amount of cardiac reserve, but at high
obutamine doses, failed to increase dP/dtmax to the same
xtent as NTG hearts. As is often seen in heart disease
atients undergoing stress echocardiography, the acute do-
utamine stress test was able to unmask the limitations in
ardiac reserve. However, we could not observe a discrete
hreshold, but rather a gradual response: the higher the
obutamine dose, the more pronounced the difference in
erformance between TG and NTG hearts. This suggests
hat there might be intermediate stages between a compen-
ated and an uncompensated response. We suspect that,
ndeed, such an intermediate state occurred in our exercised
ice: we observed a trend toward LV dilation, but no signs
f restricted exercise capacity or cardiac decompensation.
onclusions. The present study shows that cardiac expres-
ion of beta-MHC is disadvantageous under chronic iso-
roterenol challenge and in a post-infarction failure model.
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December 21, 2004:2390–7 MHC and Cardiac Stresslthough we do not believe that the murine data are directly
pplicable to human heart failure, they do imply that the
lpha3beta-MHC shift observed in human heart disease
ay be more than just a marker for the severity of the
isease state and might actually contribute to its develop-
ent. Our data validate the general approach and justify the
xtension of carrying out MHC isoform shifts in models
hat more closely resemble the human heart such as the
abbit (30). The present findings have important implica-
ions for the development of future therapeutic strategies
imed at altering the mechanical characteristics of the
HC molecule.
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